Your browser doesn't support javascript.
loading
Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.
Reed, Joseph M; Gardner, Stewart G; Mishra, Nagendra N; Bayer, Arnold S; Somerville, Greg A.
Afiliación
  • Reed JM; School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68588-0905, USA.
  • Gardner SG; School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68588-0905, USA.
  • Mishra NN; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
  • Bayer AS; Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.
  • Somerville GA; Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
J Antimicrob Chemother ; 74(8): 2274-2283, 2019 08 01.
Article en En | MEDLINE | ID: mdl-31074482

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Staphylococcus aureus / Daptomicina / Farmacorresistencia Bacteriana / Fosfomicina / Metabolismo / Antibacterianos Límite: Animals Idioma: En Revista: J Antimicrob Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Staphylococcus aureus / Daptomicina / Farmacorresistencia Bacteriana / Fosfomicina / Metabolismo / Antibacterianos Límite: Animals Idioma: En Revista: J Antimicrob Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos